Watchlist Price Alert

MBX Biosciences Inc. Comm... (MBX)

NASDAQ: MBX · Real-Time Price · USD

10.54

0.17 (1.64%)

At close: Jun 13, 2025, 3:59 PM

MBX Biosciences Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Net Income	-73.47M	-61.92M	-55.18M	-47.2M	-38.95M	-26.61M	-17.77M	-7.61M
Depreciation & Amortization	-1.15M	244K	227K	192K	168K	120K	79K	39K
Stock-Based Compensation	4.52M	2.68M	2.21M	1.61M	1.61M	1.61M	596K	n/a
Other Working Capital	710K	670K	-604K	388K	-1.58M	-1.54M	1M	-529K
Other Non-Cash Items	-1.43M	-280K	584K	1.15M	734K	-411K	95K	86K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	4.16M	4.6M	2.37M	1.39M	-528K	-962K	1.89M	102K
Operating Cash Flow	-66.65M	-54.68M	-49.79M	-42.85M	-36.96M	-26.25M	-15.11M	-7.38M
Capital Expenditures	-631K	-874K	-837K	-802K	-381K	-108K	-53K	-31K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-289.82M	-239.47M	-185.87M	-78.72M	-63.03M	-54.48M	-20.58M	n/a
Sales Maturities Of Investments	112.65M	79.75M	64.5M	39.5M	51.25M	27M	22M	20M
Other Investing Acitivies	5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-172.8M	-160.59M	-122.2M	-40.02M	-12.16M	-27.59M	1.36M	19.97M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	235.82M	235.81M	235.83M	68.52M	68.52M	68.52M	68.5M	n/a
Financial Cash Flow	233.93M	234.1M	234.25M	66.94M	69.33M	69.15M	69.13M	634K
Net Cash Flow	17.4M	36.85M	80.28M	2.08M	2.08M	2.08M	42.16M	n/a
Free Cash Flow	-67.28M	-55.55M	-50.63M	-43.65M	-37.34M	-26.36M	-15.16M	-7.41M